Kopp Family Office, LLC - Q2 2023 holdings

Add to watchlist

$186 Thousand is the total value of Kopp Family Office, LLC's 22 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

All

			Value		Shares		↓ Weighting
MODN	Buy	Model N Inc	$7,932	+97.6%	224,335	+87.0%	4.26%	+96.9%
WK	Buy	Workiva Inc	$7,765	+71.5%	76,386	+72.8%	4.17%	+70.9%
INSP	Buy	Inspire Med Sys Inc	$5,880	+76.5%	18,112	+27.2%	3.16%	+75.8%
VRDN	Buy	Viridian Therapeutics Inc	$5,098	+52.6%	214,290	+63.2%	2.74%	+52.1%

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2023-08-14

Signatures

The EDGAR filing(s) were signed by:

John P. Flakne — Chief Financial Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
NeoGenomics Inc.	16	Q3 2023	90.1%
Vericel Corporation	16	Q3 2023	14.5%
Five9, Inc.	16	Q3 2023	11.2%
ISHARES TR	13	Q3 2023	16.7%
ISHARES TR	13	Q3 2023	10.6%
ISHARES TR	13	Q3 2023	0.1%
ISHARES TR	13	Q3 2023	0.1%
ISHARES TR	13	Q3 2023	0.0%
ISHARES TR	13	Q3 2023	0.0%
ISHARES TR	13	Q3 2023	0.0%

View Kopp Family Office, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

Kopp Family Office, LLC Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
RTI Surgical Holdings, Inc.	July 07, 2020	?	?
NEOGENOMICS INC	January 07, 2020	4,844,625	4.6%
OCLARO, INC.	January 04, 2019	?	?
SUPERCONDUCTOR TECHNOLOGIES INC	October 05, 2018	?	?

View Kopp Family Office, LLC's complete significant-ownership history.

Latest filings

Type	Filed
13F-HR	2024-02-13
13F-HR	2023-11-14
13F-HR	2023-08-14
13F-HR	2023-05-15
13F-HR	2023-02-14
13F-HR	2022-11-14
13F-HR	2022-08-16
13F-HR	2022-05-16
13F-HR	2022-02-15
13F-HR	2021-11-16

View Kopp Family Office, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Kopp Family Office, LLC's holdings